CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Molecular and immunophenotypic predictors of response to azacitidine (aza) as frontline therapy for acute myeloid leukemia (AML).
Author
James Thomas Symanowski
Jonathan Michael Gerber
Michael Keith Alister Zimmerman
Michael Richard Grunwald
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Hypomethylating agent (HMA) treatment as a bridge to allogeneic hematopoietic cell transplantation (HCT) for relapsed/refractory acute myeloid leukemia (RR-AML).
Author
Belinda Rene Avalos
Brittany K. Ragon
+11Â more
Danielle Boselli
Dragos Plesca
Edward Alan Copelan
James Thomas Symanowski
Jigar S. Trivedi
Jing Ai
Jonathan Michael Gerber
Lauren M. Bohannon
Michael Keith Alister Zimmerman
Michael Richard Grunwald
Thomas Gregory Knight
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref